To investigate the effect of restricted feeding (RF) on the absorption, metabolism, and accumulation of pentachlorobenzene (PECB), rats were fed either ad libitum (AD) or a restricted diet (at 25 or 50% of AD) for 15 days. On the 7th day (day 0), PECB (15mg/rat) was orally administered. Daily fecal weight and the total amount of PECB excreted into feces were decreased by RF, indicating an increase in PECB absorption due to its prolonged retention in the gastrointestinal tract. However, the amount of PECB excreted was only 4.8% of the dose given to the AD group, and 2.1 and 2.4% of that given to the 50 and 25% restricted diet groups, respectively. The concentrations of PECB and pentachlorophenol, and major metabolite, in blood of the restricted diet groups were higher on day 2 and day 4, while lower on day 6 and day 8 than those of the AD group. On day 8, PECB in liver, kidney, brain, and fat tissue were also lower in the restricted diet groups; the PECB levels in such tissue in the 25 and 50% restricted diet groups were 10-40 and 5-11% of that in the AD group, respectively. These results indicate that PECB metabolism was increased by RF. As PECB is lipophilic, it is most likely that the fat tissue mass, which was markedly decreased by RF, contributed to the enhancement of PECB metabolism. The mechanism seemed to be as follows: as fat tissue mass accumulating PECB decreased, the concentration of PECB in the liver increased, thus the amount of PECB metabolites formed was increased. Key Words pentachlorobenzene, absorption, accumulation, metabolism, fat tissue, food restriction, rat, pentachlorophenol Various organochlorine chemicals are present in the environment such as pesticides, herbicides, and intermediate products. These chemicals are lipophilic and tend to accumulate in fat tissue for a long time without being metabolized. The mobilization of such a chemical from the fat tissue into the blood is an important step toward its metabolism in the liver and its excretion from the body. Restricted feeding (RF) and fasting lead to decreased fat tissue mass, thereby mobilizing the chemical from the fat tissue together with lipolysis and enhancing its metabolism in the liver. In addition, it has been reported that RF treatment influences the activity of the hepatic drug-metabolizing enzymes (1, 2). The effects of RF on the excretion of DDT (3, 4), hexachlorobenzene (5, 6), and hexachlorobiphenyl (7, 8) have been tested. However, the results of these reports are inconsistent. In some cases, RF effectively enhanced chemical metabolism and excretion, but in other cases the treatment led to the redistribution of the chemicals, especially from fat tissue to the brain, and increased their toxicity. In most of these studies, the effect of RF was examined after the administration of the chemicals. RF prior to the administration of the chemicals might greatly influence both the transit time of the chemicals and fat tissue mass. The transit time might affect the absorption of the chemicals in the gastrointestinal tract, and the fat tissue mass might affect the distribution of the chemicals in the body. In many reports fat tissue has been recognized as a deposition site of lipophilic chemicals. Reports concerning the influence of fat tissue on the metabolism of these chemicals are scarce.
in the liver. In addition, it has been reported that RF treatment influences the activity of the hepatic drug-metabolizing enzymes (1, 2) .
The effects of RF on the excretion of DDT (3, 4) , hexachlorobenzene (5, 6) , and hexachlorobiphenyl (7, 8) have been tested. However, the results of these reports are inconsistent. In some cases, RF effectively enhanced chemical metabolism and excretion, but in other cases the treatment led to the redistribution of the chemicals, especially from fat tissue to the brain, and increased their toxicity. In most of these studies, the effect of RF was examined after the administration of the chemicals. RF prior to the administration of the chemicals might greatly influence both the transit time of the chemicals and fat tissue mass. The transit time might affect the absorption of the chemicals in the gastrointestinal tract, and the fat tissue mass might affect the distribution of the chemicals in the body. In many reports fat tissue has been recognized as a deposition site of lipophilic chemicals. Reports concerning the influence of fat tissue on the metabolism of these chemicals are scarce.
Using pentachlorobenzene (PECB) which is lipophilic and relatively e tabolizable, we have observed that both metabolism and excretion of PECB were markedly greater in young rats than in adult rats, and that its mechanism was associated with the difference of fat tissue mass (9) . That report demonstrated that a smaller fat tissue mass enhanced the concentration of PECB in the liver, resulting in an enhancement of its metabolism through hepatic drug-metabolizing enzymes. In this report, rats were fed restricted diets one week prior to the administration of PECB, and the influence of RF on the absorption, metabolism, and accumulation of PECB was examined. The results indicate that RF increases the absorption of PECB, whereas it accelerates the metabolism of PECB by affecting the availability of the chemical to hepatic drug-metabolizing enzymes, and markedly decreases PECB residues in various tissues.
MATERIALS
AND METHODS 1) Materials. PECB, pentachlorophenol (PCP), 2-aminophenol were pur chased from Tokyo Kasei Kogyo Co., and UDP-glucuronic acid was obtained from Seikagaku Kogyo Co. Other chemicals were purchased from Wako Pure Chemical Industries. PECB was recrystallized 3 times from methanol before use.
2) Experimental animals. Male Wistar rats (6 weeks of age) obtained from Japan Clea, Tokyo, were divided into three dietary groups of 12 rats each: ad libitum (AD) group: 25% restricted diet group which was fed 75% that of the AD group; 50% restricted diet group which was fed 50% that of the AD group. The food (CE-2, Japan Clea) consumption of the AD group was measured daily and feeding in the 25 and 50% restricted diet groups was reduced to 75 and 50%, respectively, of the average food consumption of the AD group. Rats were maintained on these dietary conditions throughout the 15 days of the experimental period in metabolic cages. After one week, each group was further divided into two groups of 6 rats each: PECB-treated and untreated. PECB-treated rats received by intragastric 
RESULTS
RF significantly attenuated the increase in body weight ( Fig. 1 ). In the 50% restricted diet group, neither increase nor decrease of the body weight was observed. Body weight was decreased by overnight fasting before sacrifice was performed in the AD and 25% restricted diet groups. The ratio of liver weight to body weight was not different among the three groups. On the other hand, the ratio of fat tissue weight to body weight significantly decreased as the diet restriction rate increased (Table 1) . A marked change was observed especially in tissue weight of perirenal fat both in the 25 and 50% restricted diet groups. These decreases of the fat tissue weight by RF were almost the same as those found in a previously reported study of RF treatment for one week (17) . This suggests that the fat tissue mass had already markedly been reduced through RF by the time PECB was administered (day 0). None of the groups exhibited any changes of body weight, tissue weight or serum GPT activity due to PECB administration (data not shown). Although fecal excretion of PECB was greatest during days 0-1 regardless of the feeding condition, the amounts of PECB excreted in the 25 and 50% restricted diet groups were smaller during days 0-1 and days 3-8, but greater during days 1-2 compared with the corresponding findings of the AD group (Table 2) . Although the cumulative fecal excretion of PECB during the experimental period was significantly decreased by the RF, the amounts were only 4.8% of the dose in the AD group, and 2.4 and 2.1% in the 25 and 50% restricted diet groups, respectively. These differences in fecal PECB excretion were associated with the differences in daily fecal weight due to RF. The average daily fecal weights were 6.1g in the AD group, and 4.5 and 3.0g in the 25 and 50% restricted diet groups, respectively. The time course changes of PECB concentration in blood are shown in Table  3 . In the restricted diet groups, PECB concentration in the blood was higher until day 2 and lower after day 4 than that in the AD group. The calculated half-lives for PECB were 24h in the AD group, and 18 and 15h in the 25 and 50% restricted diet groups, respectively. The amount of PECB residues in the liver, kidney, brain, and fat tissues on day 8 in the restricted diet groups was significantly lower than that in the AD group (Table 4) . A major metabolite of PECB in the liver is PCP, which has also been detected in blood (16) . PCP detected in blood during days 1-4 of the restricted diet groups was significantly higher in concentration than that in the AD group (Table 5) . Furthermore, levels of urinary PCP, which is one of the PECB metabolites found in urine, were also higher up to day 3 in the restricted diet groups (Table 6) . Table 7 shows the changes of hepatic drug-metabolizing enzyme activity following RF and PECB administration. RF did not affect cytochrome P-450 content and UDP-glucuronyltransferase activity, but decreased glutathione S-transferase activity. PECB administration did not have any influence on these enzymes except for glutathione S-transferase, whose activity was significantly increased. The content of hepatic GSH, a reduced form of glutathione, in the restricted diet groups was significantly increased compared with that in the AD groups. PECB administration decreased GSH and increased GSSG, an oxidized form of glutathione, only in the livers from the AD group. As a result, the ratio of GSH/GSSG was significantly lower in the AD group than that in the restricted diet groups following PECB administration (Table 8 ).
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DISCUSSION
In this experiment we used PECB as a lipophilic chemical and examined the influence of RF on the absorption, metabolism, and accumulation of PECB in rats . As described in the results, although RF increased PECB absorption, it also enhanced PECB metabolism and markedly decreased PECB residue in the liver , kidney, brain, and various fat tissues.
The fecal excretion pattern of PECB could be divided into two phases with regard to its time course: the excretion of unabsorbed PECB during days 0-2, and the excretion of absorbed PECB during days 3-8. As shown in Table 2 , the reduction of food by 25 and 50% from that of the AD group markedly decreased PECB excretion in both phases. The decreased fecal excretion of PECB in the first phase indicated an ehanced absorption of PECB. The results are consistent with those reported by Villeneuve (5), who observed that the fecal excretion of hexa chlorobenzene administered at the dose of 1mg kg to rats was decreased by RF . In contrast, an increase of the fecal excretion of 2,2',4,4',5,5'-hexachlorobiphenyl (HCB) by rats on RF was reported by Wyss et al. (7) and Jondorf et al. (8) . In their studies, they used a radioactive chemical and measured the radioactivity in the fecal excretion which reflected the presence of both the parent chemical and its metabolites. Although we did not examine the fecal excretion of PECB metabolites , the enhancement of its excretion by RF may likely to have occurred. The RF-influenced decrease in the fecal excretion of PECB was inconsistent with the decrease in the PECB residue in various tissues (Table 4) . However, this discrepancy might be explained by the high absorption rate of PECB, which might obscure the differences in the fecal excretion of PECB among the AD and the restricted diet groups. As described in the RESULTS section, the total amount of PECB excreted into feces was less than a mere 4-5% of the dose in any of the AD or restricted diet groups.
Enhanced PECB metabolism due to RF was indicated by a relatively short biological half life of PECB in the blood, and high concentrations of PCP in the blood and urine. This enhanced metabolism might have reduced the level of PECB residues in various tissues. There might be at least two possibilities involved in the enhanced PECB metabolism in the restricted diet groups. One is an increase in the activity of hepatic drug-metabolizing enzymes, and the other is change of the hepatic PECB concentration as a substrate of the enzymes.
PECB accumulated in fat tissue because of its lipophilic properties, whereas PCP could not be detected in fat tissues (18) . Therefore, the transformation of PECB to PCP by cytochrome P®450 seems to be an important step in the excretion of PECB accumulated in the body. It has been observed that RF in male rats increase both hepatic cytochrome P-450 content (1, 2) and hepatic monooxygenase activity which correspond with the increase of specific isoforms of cytochrome P-450s: IIC1, IIEI, IIIAI, and IVI (19) . It has also been suggested that PECB treatment in rats induces cytochrome P-450 IIIA 1 which is induced by dexamethazone treatment (20) . In the present experiment, we only examined total content of cytochrome P-450 in the liver. Therefore, it is unclear whether RF significantly induced the cytochrome P-450 which is specific for PECB metabolism. However, no significant change of the total content of cytochrome P-450 was observed to have been brought about by RF as shown in Table 7 . This may be due to the short period of RF treatment. No increase of the cytochrome P-450 content and the small changes of conjugated enzyme activities ( Table 7 ) may indicate that the enhanced metabolism of PECB in the restricted diet groups was not likely to be due to the changes in the activity of the hepatic drug metabolizing enzymes per se. Further study will need to clearify how the changes of hepatic drug-metabolizing enzymes contribute to the RF-influenced increase in PECB metabolism.
As shown in Table 1 , RF markedly reduced the fat tissue mass in which a large amount of PECB is accumulated without metabolic transformation. The decrease in fat tissue mass reduces its capacity to store PECB there, increases PECB concentrations in the blood and liver, and thus accelerates PECB metabolism by the hepatic drug-metabolizing enzymes. This is supported by the facts that blood concentrations of PECB on days 1-2 and PCP on days 1-4 in the restricted diet groups were significantly higher than those in the AD group (Tables 3 and 5 ), and that the biological half-life of PECB in rats was approximately one day (18) . These phenomena were quite similar to those observed in an experiment using young and adult rats (9) . In young rats, the fat tissue mass was smaller and the activity of hepatic drug-metabolizing enzymes was lower when compared to adult rats. After the administration of PECB, the metabolism of PECB in young rats was at a much higher rate than that in adult rats: the biological half-life of PECB in the blood was 10.6h in young rats and 42.9h in adult rats. In that experiment, the changes in PECB and PCP concentrations in the blood were similar to those found in the present experiment. Birnbaum (21) has pointed out that the decrease in the clearance of hexachlorobiphenyl from the systems of older animals was related to the increase et al. 
